Research Article

You have full text access to this OnlineOpen article

Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors

  1. Markus M. J. Nielen1,
  2. Dirkjan van Schaardenburg2,
  3. Henk W. Reesink3,
  4. Rob J. van de Stadt1,
  5. Irene E. van der Horst-Bruinsma4,
  6. Margret H. M. T. de Koning1,
  7. Moud R. Habibuw3,
  8. Jan P. Vandenbroucke5,
  9. Ben A. C. Dijkmans2,*

Article first published online: 5 FEB 2004

DOI: 10.1002/art.20018

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 50, Issue 2, pages 380–386, February 2004

Additional Information

How to Cite

Nielen, M. M. J., van Schaardenburg, D., Reesink, H. W., van de Stadt, R. J., van der Horst-Bruinsma, I. E., de Koning, M. H. M. T., Habibuw, M. R., Vandenbroucke, J. P. and Dijkmans, B. A. C. (2004), Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis & Rheumatism, 50: 380–386. doi: 10.1002/art.20018

Author Information

  1. 1

    Jan van Breemen Institute, Amsterdam, The Netherlands

  2. 2

    Jan van Breemen Institute and Vrije Universiteit Medical Centre, Amsterdam, The Netherlands

  3. 3

    Sanquin Blood Bank Northwest Region, Amsterdam, The Netherlands

  4. 4

    Vrije Universiteit Medical Centre, Amsterdam, The Netherlands

  5. 5

    Leiden University Medical Center, Leiden, The Netherlands

*Department of Rheumatology, Vrije Universiteit Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands

Publication History

  1. Issue published online: 5 FEB 2004
  2. Article first published online: 5 FEB 2004
  3. Manuscript Accepted: 1 OCT 2003
  4. Manuscript Received: 15 MAY 2003

Funded by

  • Dutch Arthritis Association

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (152K)

REFERENCES

  • 1
    Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984; 27: 864–72.
    Direct Link:
  • 2
    Scott DL, Symmons DP, Coulton BL, Popert AJ. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1987; 1: 1108–11.
  • 3
    Van Jaarsveld CH, Jacobs JW, van der Veen MJ, Blaauw AA, Kruize AA, Hofman DM, et al, on behalf of the Rheumatic Research Foundation Utrecht, The Netherlands. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis 2000; 59: 468–77.
  • 4
    Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997; 350: 309–18.
  • 5
    Mottonen T, Hannonen P, Leirisalo-Repo M, Nissila M, Kautiainen H, Korpela M, et al, FIN-RACo Trial Group. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 1999; 353: 1568–73.
  • 6
    Bukhari M, Harrison B, Lunt M, Scott DGI, Symmons DPM, Silman AJ. Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum 2001; 44: 1248–53.
    Direct Link:
  • 7
    Combe B, Dougados M, Goupille P, Cantagrel A, Eliaou JF, Sibilia J, et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum 2001; 44: 1736–43.
    Direct Link:
  • 8
    Hulsmans HMJ, Jacobs JWG, van der Heijde DMFM, Albada-Kuipers GA, Schenk Y, Bijlsma JWJ. The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis Rheum 2000; 43: 1927–40.
    Direct Link:
  • 9
    Kraan MC, Versendaal H, Jonker M, Bresnihan B, Post WJ, "t Hart BA, et al. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis Rheum 1998; 41: 1481–8.
    Direct Link:
  • 10
    Silman AJ, Hennessy E, Ollier B. Incidence of rheumatoid arthritis in a genetically predisposed population. Br J Rheumatol 1992; 31: 365–8.
  • 11
    Aho K, Heliovaara M, Maatela J, Tuomi T, Palosuo T. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991; 18: 1282–4.
  • 12
    Kurki P, Aho K, Palosuo T, Heliövaara M. Immunopathology of rheumatoid arthritis: antikeratin antibodies precede the clinical disease. Arthritis Rheum 1992; 35: 914–7.
    Direct Link:
  • 13
    Halldorsdottir HD, Jonsson T, Thorsteinsson J, Valdimarsson H. A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor. Ann Rheum Dis 2000; 59: 149–51.
  • 14
    Del Puente A, Knowler WC, Pettitt DJ, Bennett PH. The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study. Arthritis Rheum 1988; 31: 1239–44.
    Direct Link:
  • 15
    Walker DJ, Pound JD, Griffiths ID, Powell RJ. Rheumatoid factor tests in the diagnosis and prediction of rheumatoid arthritis. Ann Rheum Dis 1986; 45: 684–90.
  • 16
    Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273–81.
  • 17
    Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000; 2: 236–43.
  • 18
    Schellekens GA, Visser H, de Jong BAW, van den Hoogen FHJ, Hazes JMW, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155–63.
    Direct Link:
  • 19
    Jansen LMA, van der Horst Bruinsma IE, van Schaardenburg D, van de Stadt RJ, de Koning MHMT, Dijkmans BAC. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002, 29: 2074–6.
  • 20
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24.
    Direct Link:
  • 21
    Klein F, Janssens MB. Standardisation of serological tests for rheumatoid factor measurement. Ann Rheum Dis 1987; 46: 674–80.
  • 22
    Molenaar ET, Lems WF, Dijkmans BA, de Koning MH, van de Stadt RJ, Voskuyl AE. Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 742–4.
  • 23
    Chorus AMJ. Reuma in Nederland: de cijfers. Actualisering 2000. TNO-rapport 2001: 27.
  • 24
    Kessel A, Rosner I, Zuckerman E, Golan TD, Toubi E. Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection. J Rheumatol 2000; 27: 610–2.
  • 25
    Aho K, Koskela P, Makitalo R, Heliovaara M, Palosuo T. Antinuclear antibodies heralding the onset of systemic lupus erythematosus. J Rheumatol 1992; 19: 1377–9.
  • 26
    Tuomilehto J, Zimmet P, Mackay IR, Koskela P, Vidgren G, Toivanen L, et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 1994; 343: 1383–5.
  • 27
    Carel JC, Boitard C, Eisenbarth G, Bach JF, Bougneres PF. Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children. J Autoimmun 1996; 9: 739–45.
  • 28
    Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346: 1685–91.
  • 29
    Walker DJ, Griffiths M, Dewar P, Coates E, Dick WC, Thompson M, et al. Association of MHC antigens with susceptibility to and severity of rheumatoid arthritis in multicase families. Ann Rheum Dis 1985; 44: 519–25.
View Full Article (HTML) Get PDF (152K)